ReviewCurrent drug targets2025
Lipidomics in Breast Cancer: Decoding Metabolic Reprogramming and Unlocking Therapeutic Opportunities.
Harshita Singhai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it